YESHIVA UNIVERSITY and Montefiore Health System agreed to have Montefiore assume greater responsibility for the day-to-day operations and financial management of Albert Einstein College of Medicine, with Yeshiva remaining the degree-granting institution.
HIROMITSU OTA received the 2014 Ching Jer Chern Memorial Award from The Wistar Institute.
SANDEEP REDDY was named chief medical officer of Caris Life Sciences.
PATRICIA LORUSSO was named associate director of innovative medicine at Yale Cancer Center. She will take the job in August, and will also serve as a professor of medicine.
CORINNE AUGELLI-SZAFRAN was named director of chemistry at Southern Research Institute.
The Health Resources and Services Administration said it stands by its interpretation of the Affordable Care Act orphan drug exclusion, despite a recent court ruling that challenged its authority to engage in legislative rulemaking.
BALTIMORE—Constructed in Germany, shipped to the port of Baltimore, and driven through downtown during the night, the 90-ton cyclotron arrived at the University of Maryland's Proton Treatment Center.
The Cancer Letter asked David Wholley, director of the Foundation for the National Institutes of Health Biomarker Consortium, to explain the novel scientific and administrative structure of Lung-MAP.
Registration Trial DesignLung-MAP is designed to provide a fast, efficient path to full approval, said Roy Herbst, co-chair of the trial's steering committee and co-chair of its executive operations group. The idea is to get drugs to patients throughout the community, going seamlessly from a phase II portion to phase III, with all patients counting toward registration.
SWOG earlier this week started to accrue patients to Lung-MAP, a clinical trial for second-line treatment of non-small cell lung cancer.
